Point72 (Difc) LTD Intra Cellular Therapies, Inc. Transaction History
Point72 (Difc) LTD
- $2.81 Trillion
- Q2 2024
A detailed history of Point72 (Difc) LTD transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Point72 (Difc) LTD holds 20,385 shares of ITCI stock, worth $1.49 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
20,385Holding current value
$1.49 Million% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding ITCI
# of Institutions
400Shares Held
87.2MCall Options Held
309KPut Options Held
302K-
Vanguard Group Inc Valley Forge, PA9.61MShares$702 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$462 Million0.01% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.72MShares$272 Million1.37% of portfolio
-
Jpmorgan Chase & CO New York, NY3.44MShares$251 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY3MShares$219 Million2.8% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $6.9B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...